Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Glenmark Pharmaceuticals Ltd

NSE: GLENMARK · BSE: 532296 · Pharmaceuticals & Biotechnology · 39 announcements

Glenmark Pharmaceuticals Ltd news stories on ALFA NewsRead the news →
Share price
₹2,293.50
Market cap
₹64,728 Cr
Revenue (annual)
₹16,983 Cr
Net profit (annual)
₹1,362 Cr
P/E (TTM)
36.0×Sector 47.4×
Promoter holding
46.65%+0.00% QoQ
FII holding
20.89%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

18:54 IST NSE
Annual General Meeting

Glenmark Pharmaceuticals Annual General Meeting

Glenmark Pharmaceuticals held its 48th Annual General Meeting on September 11, 2026. The company submitted the proceedings, Scrutinizer’s Report, and voting results to the exchanges.

19:55 IST NSE
Annual General Meeting

Glenmark Pharmaceuticals Annual General Meeting

Glenmark Pharmaceuticals Limited has issued the notice for its 48th Annual General Meeting, scheduled to be held on September 11, 2026, through video conferencing.